These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18191566)
1. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators. Tyrrell E; Tesfa KH; Greenwood I; Mann A Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566 [TBL] [Abstract][Full Text] [Related]
2. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position. Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435 [TBL] [Abstract][Full Text] [Related]
3. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis. Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781 [TBL] [Abstract][Full Text] [Related]
4. [Synthesis and bioactivity of some 3,4-diacyloxybenzopyrans]. Yan Z; Huang WL; Peng SX; Hua WY Yao Xue Xue Bao; 1997; 32(2):97-105. PubMed ID: 11243208 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim. Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075 [TBL] [Abstract][Full Text] [Related]
6. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers. Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154 [TBL] [Abstract][Full Text] [Related]
7. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener. Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim. Khelili S; Lebrun P; de Tullio P; Pirotte B Bioorg Med Chem; 2006 May; 14(10):3530-4. PubMed ID: 16455262 [TBL] [Abstract][Full Text] [Related]
9. [Potassium channel activators: comparative structural study of pinacidil, diazoxide and cromakalim]. Dupont L; Pirotte B; de Tullio P; Masereel B; Delarge J Ann Pharm Fr; 1995; 53(5):201-8. PubMed ID: 7503508 [TBL] [Abstract][Full Text] [Related]
10. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent. Thompson R; Doggrell S; Hoberg JO Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752 [TBL] [Abstract][Full Text] [Related]
11. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines. Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302 [TBL] [Abstract][Full Text] [Related]
12. Time-dependent alteration in cromakalim-induced relaxation of corpus cavernosum from streptozocin-induced diabetic rats. Ghasemi M; Sadeghipour H; Asadi S; Dehpour AR Life Sci; 2007 Sep; 81(12):960-9. PubMed ID: 17825847 [TBL] [Abstract][Full Text] [Related]
13. Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel. Breschi MC; Calderone V; Digiacomo M; Manganaro M; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A J Med Chem; 2008 Nov; 51(21):6945-54. PubMed ID: 18925735 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies. Bakonyi A; Horváth EJ Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310. Shin HS; Seo HW; Yoo SE; Lee BH Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610 [TBL] [Abstract][Full Text] [Related]
16. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone. Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators. Khelili S; Florence X; Bouhadja M; Abdelaziz S; Mechouch N; Mohamed Y; de Tullio P; Lebrun P; Pirotte B Bioorg Med Chem; 2008 Jun; 16(11):6124-30. PubMed ID: 18479927 [TBL] [Abstract][Full Text] [Related]
18. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat. Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439 [TBL] [Abstract][Full Text] [Related]